GABA-B Pharmaceutical composition for the prevention or treatment of depressive or anxiety symptoms through nasal administration of GABA-B receptor antagonists or agonists

摘要

The present invention is a pharmaceutical composition for the treatment of depression or anxiety symptoms through nasal administration of a GABA-B receptor antagonist or an agonist, and more specifically, it is possible to reduce anxiety by nasal administration of the antagonist, and by nasal administration of the agonist It is to provide a pharmaceutical composition that can relieve depression symptoms. According to the present invention, it is possible to differentiate between a depressive disorder patient and an anxiety disorder patient to access treatment, and it is expected that a lesser amount of neurotransmitters can be used to effectively prevent or treat depression and/or anxiety symptoms.